Discharge Pain Medications: Do They Affect 6-Month Patient-Reported Outcomes After Operative Treatment of CMC Arthritis?

IF 1.8 Q2 ORTHOPEDICS

HAND Pub Date : 2024-11-24 DOI:10.1177/15589447241298979

Mariah N Wegner, Rebekah M Kleismith, Stephen A Doxey, Andrew Sibley, Jeffrey B Husband, Deborah C Bohn, Brian P Cunningham

{"title":"Discharge Pain Medications: Do They Affect 6-Month Patient-Reported Outcomes After Operative Treatment of CMC Arthritis?","authors":"Mariah N Wegner, Rebekah M Kleismith, Stephen A Doxey, Andrew Sibley, Jeffrey B Husband, Deborah C Bohn, Brian P Cunningham","doi":"10.1177/15589447241298979","DOIUrl":null,"url":null,"abstract":"Background: The purpose of this study is to analyze the relationship between discharge opioids after operative treatment of carpometacarpal (CMC) arthritis and patient-reported outcomes (PROs) over a 6-month episode of care.Methods: A total of 172 patients met inclusion criteria for this study. Patient-reported outcomes including patient-reported wrist/hand evaluation (PRWHE), single assessment numeric evaluation, and PRO measurement information system (PROMIS) global-10 questionnaires were collected prospectively and stored in an electronic data capture system until review for the purpose of this study. Morphine milligram equivalents (MMEs) were calculated using a Centers for Disease Control and Prevention-published opioid conversion table.Results: Of the 172 patients who met inclusion criteria for this study, 121 (70.4%) were female. The average patient age on the day of procedure was 63.6 ± 7.4 years. All patients received a prescription pain medication upon discharge with an average of 191.3 MMEs (range: 40.00-800.00 MMEs) prescribed per patient. Overall, there was no correlation between the amount of pain medication prescribed in MMEs and change in PROs between baseline, 6-weeks, 3-months, and 6-months (r < .14).Discussion: Surgeons should feel confident limiting postoperative opioid prescription for patients after CMC arthroplasty without jeopardizing outcomes.","PeriodicalId":12902,"journal":{"name":"HAND","volume":" ","pages":"15589447241298979"},"PeriodicalIF":1.8000,"publicationDate":"2024-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"HAND","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/15589447241298979","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ORTHOPEDICS","Score":null,"Total":0}

引用次数: 0

Abstract

Background: The purpose of this study is to analyze the relationship between discharge opioids after operative treatment of carpometacarpal (CMC) arthritis and patient-reported outcomes (PROs) over a 6-month episode of care.

Methods: A total of 172 patients met inclusion criteria for this study. Patient-reported outcomes including patient-reported wrist/hand evaluation (PRWHE), single assessment numeric evaluation, and PRO measurement information system (PROMIS) global-10 questionnaires were collected prospectively and stored in an electronic data capture system until review for the purpose of this study. Morphine milligram equivalents (MMEs) were calculated using a Centers for Disease Control and Prevention-published opioid conversion table.

Results: Of the 172 patients who met inclusion criteria for this study, 121 (70.4%) were female. The average patient age on the day of procedure was 63.6 ± 7.4 years. All patients received a prescription pain medication upon discharge with an average of 191.3 MMEs (range: 40.00-800.00 MMEs) prescribed per patient. Overall, there was no correlation between the amount of pain medication prescribed in MMEs and change in PROs between baseline, 6-weeks, 3-months, and 6-months (r < .14).

Discussion: Surgeons should feel confident limiting postoperative opioid prescription for patients after CMC arthroplasty without jeopardizing outcomes.

查看原文本刊更多论文

出院止痛药物：它们会影响 CMC 关节炎手术治疗后 6 个月的患者报告结果吗？

背景：本研究旨在分析腕掌关节炎（CMC）手术治疗后出院阿片类药物与 6 个月护理期间患者报告结果（PROs）之间的关系：共有 172 名患者符合本研究的纳入标准。患者报告结果包括患者报告的腕部/手部评估（PRWHE）、单一评估数字评估和PRO测量信息系统（PROMIS）全球-10调查问卷，这些结果都是前瞻性收集的，并存储在电子数据采集系统中，直到为本研究的目的进行审查。使用美国疾病控制和预防中心公布的阿片类药物换算表计算吗啡毫克当量（MMEs）：在符合本研究纳入标准的 172 名患者中，121 人（70.4%）为女性。手术当天患者的平均年龄为 63.6 ± 7.4 岁。所有患者在出院时都接受了处方止痛药，每位患者平均接受了 191.3 毫克/分钟（范围：40.00-800.00 毫克/分钟）的处方止痛药。总体而言，在基线、6周、3个月和6个月期间，处方止痛药的MMEs量与PROs的变化之间没有相关性（r < .14）：讨论：外科医生应该有信心限制 CMC 关节置换术后患者的术后阿片类药物处方，而不影响治疗效果。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

HAND Medicine-Surgery

CiteScore

3.30

自引率

0.00%

发文量

209

期刊介绍： HAND is the official journal of the American Association for Hand Surgery and is a peer-reviewed journal featuring articles written by clinicians worldwide presenting current research and clinical work in the field of hand surgery. It features articles related to all aspects of hand and upper extremity surgery and the post operative care and rehabilitation of the hand.